ABSTRACT
The parallel development of instrumentation and the chemistry of clinically useful isotopes has maintained nuclear medicine as a premier diagnostic imaging service. The distribution of labeled radiopharmaceuticals in the body allows imaging of organ function since these chemical substances are actively accumulated (e.g. MDP bone agents, liver colloid) or excreted (e.g. DTPA, EHIDA) by the target organ.
